Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-04-04 Sale | 2022-04-05 08:17 am | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 1,091 | $1.25 | $1,364 | 68,330 (Direct) | View |
2022-03-16 Sale | 2022-03-17 4:09 pm | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 2,717 | $1.1 | $2,989 | 163,171 (Direct) | View |
2021-04-02 Sale | 2022-03-16 5:29 pm | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 1,472 | $2.5391 | $3,738 | 48,700 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-15 Option Award | 2022-03-17 4:09 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 125,000 | $0 | 163,171 (Direct) | View |
2021-03-15 Option Award | 2021-03-17 1:50 pm | N/A 2031-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 225,000 | $0 | 225,000 (Direct) | View |
2020-06-01 Option Award | 2020-06-02 4:24 pm | N/A 2030-06-01 | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 31,561 | $0 | 31,561 (Direct) | View |
2020-04-02 Option Award | 2020-04-06 4:18 pm | N/A 2030-04-02 | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 58,612 | $0 | 58,612 (Direct) | View |